MedComm-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241833, encodeId=f673224183312, content=这个杂志为什么小修了，还换主编？而且小修还审稿2周？审稿人一个问题也没有了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 11 15:09:40 CST 2024, time=2024-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236780, encodeId=18a52236e8033, content=好奇什么时候可以上SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ee5439551, createdName=好运丫, createdTime=Wed Nov 13 20:19:31 CST 2024, time=2024-11-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233241, encodeId=fd5a2233241d4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;基础研究;综述 经验分享：接收了，还是封面文章。感谢编辑们嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Sat Oct 26 12:21:11 CST 2024, time=2024-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2224040, encodeId=1e282224040e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3.20投稿，ADM: 为魏院士，6.22回来初审意见，8.31返修回去，第五天9.4变为 ADM: Lee, Cherish，Under Review，有这样变ADM的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=shuchao, createdTime=Wed Sep 04 15:50:25 CST 2024, time=2024-09-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省)]

2024-12-25 1481ab03m35(暂无昵称) 来自上海

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：癌症治疗
经验分享：总体从投到接收一共小5个月多；
一审50天，4个审稿人，外加编辑意见（大修）；
二审45天，审稿人没有意见，编辑部分意见（小修）；
三审20天，接收；
期间包含格式审查等一系列状态变化；
总体，审稿严谨，文章质量不错；
各位需要耐心等待，每个环节都是很严谨的。

0 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241833, encodeId=f673224183312, content=这个杂志为什么小修了，还换主编？而且小修还审稿2周？审稿人一个问题也没有了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 11 15:09:40 CST 2024, time=2024-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236780, encodeId=18a52236e8033, content=好奇什么时候可以上SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ee5439551, createdName=好运丫, createdTime=Wed Nov 13 20:19:31 CST 2024, time=2024-11-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233241, encodeId=fd5a2233241d4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;基础研究;综述 经验分享：接收了，还是封面文章。感谢编辑们嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Sat Oct 26 12:21:11 CST 2024, time=2024-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2224040, encodeId=1e282224040e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3.20投稿，ADM: 为魏院士，6.22回来初审意见，8.31返修回去，第五天9.4变为 ADM: Lee, Cherish，Under Review，有这样变ADM的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=shuchao, createdTime=Wed Sep 04 15:50:25 CST 2024, time=2024-09-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省)]

2024-12-11 1481ab03m35(暂无昵称) 来自上海

这个杂志为什么小修了，还换主编？而且小修还审稿2周？审稿人一个问题也没有了啊

44 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241833, encodeId=f673224183312, content=这个杂志为什么小修了，还换主编？而且小修还审稿2周？审稿人一个问题也没有了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 11 15:09:40 CST 2024, time=2024-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236780, encodeId=18a52236e8033, content=好奇什么时候可以上SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ee5439551, createdName=好运丫, createdTime=Wed Nov 13 20:19:31 CST 2024, time=2024-11-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233241, encodeId=fd5a2233241d4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;基础研究;综述 经验分享：接收了，还是封面文章。感谢编辑们嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Sat Oct 26 12:21:11 CST 2024, time=2024-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2224040, encodeId=1e282224040e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3.20投稿，ADM: 为魏院士，6.22回来初审意见，8.31返修回去，第五天9.4变为 ADM: Lee, Cherish，Under Review，有这样变ADM的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=shuchao, createdTime=Wed Sep 04 15:50:25 CST 2024, time=2024-09-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省)]

2024-12-09 ms5000000789056051 来自北京

偏重的研究方向：流行病;肿瘤
经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见

11 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241833, encodeId=f673224183312, content=这个杂志为什么小修了，还换主编？而且小修还审稿2周？审稿人一个问题也没有了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 11 15:09:40 CST 2024, time=2024-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236780, encodeId=18a52236e8033, content=好奇什么时候可以上SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ee5439551, createdName=好运丫, createdTime=Wed Nov 13 20:19:31 CST 2024, time=2024-11-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233241, encodeId=fd5a2233241d4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;基础研究;综述 经验分享：接收了，还是封面文章。感谢编辑们嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Sat Oct 26 12:21:11 CST 2024, time=2024-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2224040, encodeId=1e282224040e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3.20投稿，ADM: 为魏院士，6.22回来初审意见，8.31返修回去，第五天9.4变为 ADM: Lee, Cherish，Under Review，有这样变ADM的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=shuchao, createdTime=Wed Sep 04 15:50:25 CST 2024, time=2024-09-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省)]

2024-11-12 COCO-么么哒来自四川省

2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受
感谢编辑和审稿人的辛勤付出

47 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241833, encodeId=f673224183312, content=这个杂志为什么小修了，还换主编？而且小修还审稿2周？审稿人一个问题也没有了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 11 15:09:40 CST 2024, time=2024-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236780, encodeId=18a52236e8033, content=好奇什么时候可以上SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ee5439551, createdName=好运丫, createdTime=Wed Nov 13 20:19:31 CST 2024, time=2024-11-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233241, encodeId=fd5a2233241d4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;基础研究;综述 经验分享：接收了，还是封面文章。感谢编辑们嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Sat Oct 26 12:21:11 CST 2024, time=2024-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2224040, encodeId=1e282224040e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3.20投稿，ADM: 为魏院士，6.22回来初审意见，8.31返修回去，第五天9.4变为 ADM: Lee, Cherish，Under Review，有这样变ADM的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=shuchao, createdTime=Wed Sep 04 15:50:25 CST 2024, time=2024-09-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省)]

2024-10-27 ms2000001504230883 来自广西

同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？

53 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241833, encodeId=f673224183312, content=这个杂志为什么小修了，还换主编？而且小修还审稿2周？审稿人一个问题也没有了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 11 15:09:40 CST 2024, time=2024-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236780, encodeId=18a52236e8033, content=好奇什么时候可以上SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ee5439551, createdName=好运丫, createdTime=Wed Nov 13 20:19:31 CST 2024, time=2024-11-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233241, encodeId=fd5a2233241d4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;基础研究;综述 经验分享：接收了，还是封面文章。感谢编辑们嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Sat Oct 26 12:21:11 CST 2024, time=2024-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2224040, encodeId=1e282224040e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3.20投稿，ADM: 为魏院士，6.22回来初审意见，8.31返修回去，第五天9.4变为 ADM: Lee, Cherish，Under Review，有这样变ADM的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=shuchao, createdTime=Wed Sep 04 15:50:25 CST 2024, time=2024-09-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省)]

2024-11-13 好运丫来自湖南省

好奇什么时候可以上SCI

20 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241833, encodeId=f673224183312, content=这个杂志为什么小修了，还换主编？而且小修还审稿2周？审稿人一个问题也没有了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 11 15:09:40 CST 2024, time=2024-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236780, encodeId=18a52236e8033, content=好奇什么时候可以上SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ee5439551, createdName=好运丫, createdTime=Wed Nov 13 20:19:31 CST 2024, time=2024-11-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233241, encodeId=fd5a2233241d4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;基础研究;综述 经验分享：接收了，还是封面文章。感谢编辑们嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Sat Oct 26 12:21:11 CST 2024, time=2024-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2224040, encodeId=1e282224040e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3.20投稿，ADM: 为魏院士，6.22回来初审意见，8.31返修回去，第五天9.4变为 ADM: Lee, Cherish，Under Review，有这样变ADM的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=shuchao, createdTime=Wed Sep 04 15:50:25 CST 2024, time=2024-09-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省)]

2024-10-26 ms6000001702952186 来自河南省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;基础研究;综述
经验分享：接收了，还是封面文章。感谢编辑们嘿嘿

53 0

[GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241833, encodeId=f673224183312, content=这个杂志为什么小修了，还换主编？而且小修还审稿2周？审稿人一个问题也没有了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 11 15:09:40 CST 2024, time=2024-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236780, encodeId=18a52236e8033, content=好奇什么时候可以上SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ee5439551, createdName=好运丫, createdTime=Wed Nov 13 20:19:31 CST 2024, time=2024-11-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233241, encodeId=fd5a2233241d4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;基础研究;综述 经验分享：接收了，还是封面文章。感谢编辑们嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Sat Oct 26 12:21:11 CST 2024, time=2024-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2224040, encodeId=1e282224040e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3.20投稿，ADM: 为魏院士，6.22回来初审意见，8.31返修回去，第五天9.4变为 ADM: Lee, Cherish，Under Review，有这样变ADM的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=shuchao, createdTime=Wed Sep 04 15:50:25 CST 2024, time=2024-09-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省)]

2024-09-04 shuchao 来自湖南省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：3.20投稿，ADM: 为魏院士，6.22回来初审意见，8.31返修回去，第五天9.4变为 ADM: Lee, Cherish，Under Review，有这样变ADM的嘛

72 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241833, encodeId=f673224183312, content=这个杂志为什么小修了，还换主编？而且小修还审稿2周？审稿人一个问题也没有了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 11 15:09:40 CST 2024, time=2024-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236780, encodeId=18a52236e8033, content=好奇什么时候可以上SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ee5439551, createdName=好运丫, createdTime=Wed Nov 13 20:19:31 CST 2024, time=2024-11-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233241, encodeId=fd5a2233241d4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;基础研究;综述 经验分享：接收了，还是封面文章。感谢编辑们嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Sat Oct 26 12:21:11 CST 2024, time=2024-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2224040, encodeId=1e282224040e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3.20投稿，ADM: 为魏院士，6.22回来初审意见，8.31返修回去，第五天9.4变为 ADM: Lee, Cherish，Under Review，有这样变ADM的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=shuchao, createdTime=Wed Sep 04 15:50:25 CST 2024, time=2024-09-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省)]

2023-12-17 ms5078924656919134 来自上海

修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了

141 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2244805, encodeId=7efa22448056c, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：癌症治疗 经验分享：总体从投到接收一共小5个月多； 一审50天，4个审稿人，外加编辑意见（大修）； 二审45天，审稿人没有意见，编辑部分意见（小修）； 三审20天，接收； 期间包含格式审查等一系列状态变化； 总体，审稿严谨，文章质量不错； 各位需要耐心等待，每个环节都是很严谨的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 25 15:19:46 CST 2024, time=2024-12-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241833, encodeId=f673224183312, content=这个杂志为什么小修了，还换主编？而且小修还审稿2周？审稿人一个问题也没有了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0205268839, createdName=1481ab03m35(暂无昵称), createdTime=Wed Dec 11 15:09:40 CST 2024, time=2024-12-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241584, encodeId=07b222415842e, content=偏重的研究方向：流行病;肿瘤 经验分享：6月底投稿，8月底大修，10月底修回，现在一个半月了，还在under review，不知道啥时候能返回来意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=541b8156830, createdName=ms5000000789056051, createdTime=Mon Dec 09 22:33:37 CST 2024, time=2024-12-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2236541, encodeId=e97722365414b, content=2024.7.16投稿，2024.9.3一审完大修，2024.10.10修回，2024.11.7二审完小修，2024.11.11修回，2024.11.12接受 感谢编辑和审稿人的辛勤付出, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5f851664041, createdName=COCO-么么哒, createdTime=Tue Nov 12 18:18:37 CST 2024, time=2024-11-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2233318, encodeId=36742233318e5, content=同志们为啥一直处于Awaiting AE Assignment呀，咋回事这是？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sun Oct 27 00:46:05 CST 2024, time=2024-10-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2236780, encodeId=18a52236e8033, content=好奇什么时候可以上SCI, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ee5439551, createdName=好运丫, createdTime=Wed Nov 13 20:19:31 CST 2024, time=2024-11-13, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2233241, encodeId=fd5a2233241d4, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;基础研究;综述 经验分享：接收了，还是封面文章。感谢编辑们嘿嘿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb45610969, createdName=ms6000001702952186, createdTime=Sat Oct 26 12:21:11 CST 2024, time=2024-10-26, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2224040, encodeId=1e282224040e2, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：3.20投稿，ADM: 为魏院士，6.22回来初审意见，8.31返修回去，第五天9.4变为 ADM: Lee, Cherish，Under Review，有这样变ADM的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8b65561438, createdName=shuchao, createdTime=Wed Sep 04 15:50:25 CST 2024, time=2024-09-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2175362, encodeId=981121e536202, content=修回之后under review之后变成pending recommendation，但是后来又under review了。这是有审稿人不满意吗，还是审稿人不够啊…而且也太慢太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83epxYEMeM41N9n76P8Xn6Fy2L47YtWpP4fVuUZMZSAYnf6zW01CJWE2u7iaMTUicChIOKdsvNibjS3q7w/0, createdBy=f1fd2219511, createdName=ms5078924656919134, createdTime=Sun Dec 17 03:09:26 CST 2023, time=2023-12-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2209054, encodeId=206e220905457, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：基础研究 经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/d5b9725163204491b176bcaa0ee488be.jpg, createdBy=d4b72283806, createdName=red cell, createdTime=Sun Jun 09 08:44:04 CST 2024, time=2024-06-09, status=1, ipAttribution=陕西省)]

2024-06-09 red cell 来自陕西省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：基础研究
经验分享：从顶刊一直偷下来，到了medcomm一审接近三个月，小修1个多月，最后接收。有幸选为封面，最近也审了几篇medcomm的稿子，怎么说呢?大部分质量还行，实时影响因子也超10分了，月底公布的23年IF应该也是大于10的，唯一缺点就是还不算是sci。

123 7

展开7条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务